Next Article in Journal
Symptom Prevalence in Spanish and Colombian Oncology Patients Measured with the MSAS
Next Article in Special Issue
Where Do We Stand in the Management of Oligometastatic Prostate Cancer? A Comprehensive Review
Previous Article in Journal
Does Inflammation Contribute to Cancer Incidence and Mortality during Aging? A Conceptual Review
Previous Article in Special Issue
Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
 
 
Article
Peer-Review Record

High Keratin-7 Expression in Benign Peri-Tumoral Prostatic Glands Is Predictive of Bone Metastasis Onset and Prostate Cancer-Specific Mortality

Cancers 2022, 14(7), 1623; https://doi.org/10.3390/cancers14071623
by Charles Dariane 1,2,3,*, Sylvie Clairefond 1,†, Benjamin Péant 1, Laudine Communal 1, Zhe Thian 4, Véronique Ouellet 1, Dominique Trudel 1,5, Nazim Benzerdjeb 5,6, Feryel Azzi 1,6, Arnaud Méjean 2, Marc-Olivier Timsit 2, Manon Baurès 3, Jacques-Emmanuel Guidotti 3, Vincent Goffin 3, Pierre I. Karakiewicz 4,7, Anne-Marie Mes-Masson 1,8 and Fred Saad 1,7
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Cancers 2022, 14(7), 1623; https://doi.org/10.3390/cancers14071623
Submission received: 9 March 2022 / Accepted: 21 March 2022 / Published: 23 March 2022
(This article belongs to the Special Issue Advanced Prostate Cancer: From Bench to Bedside)

Round 1

Reviewer 1 Report

The authors addressed all the comments and manuscript can be accepted now.

Reviewer 2 Report

The authors have addressed all my concerns, and improved their manuscript.

Back to TopTop